Sabby Management »

Redhill Biopharma shares owned by Sabby Management

Quarter-by-quarter ownership of Redhill Biopharma (RDHL) shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in Redhill Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Redhill Biopharma held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Redhill Biopharma by Sabby Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $324k 635k 0.51

More positions owned by Sabby Management

Ishares Tr Etf Put Option
SPDR S&P 500 Etf Put Option
Ishares Tr Etf (IWM)
SPDR S&P 500 Etf (SPY)
Apricus Biosciences
Tuanche Ads
Recon Technology Cl A (RCON)
Biora Therapeutics Ord (BIOR)
Akari Therapeutics Adr
Tonix Pharmaceuticals Hldg (TNXP)
Reviva Pharmaceutcls Hldgs I Put Option
Reviva Pharmaceutcls Hldgs I Call Option
Nisun Intl Ent Dvpmt Gp SHS (NISN)
Integrity Applications (GCTK)
Dogness Intl Corp Cl A

View all positions for Sabby Management

Top funds holding Redhill Biopharma

Gagnon Securities
Jane Street
Rhumbline Advisers
We Are One Seven
Squarepoint Ops
Aspire Private Capital
Royal Bank of Canada
Steward Partners Investment Advisory
Citigroup
UBS Group
Advisor Group Holdings
Bank of America Corporation
Atlantic Edge Private Wealth Management
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Redhill Biopharma